Prospective comparison of diagnostic tests for bile acid diarrhoea
Alimentary Pharmacology & Therapeutics · 2024-01 · 59 (1) · 39-50
DOI: 10.1111/apt.17739 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 05.10.2023. Verfasst von Christian Borup und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Zealand University Hospital, Køge, Køge, Denmark. Hauptthemen laut MEDLINE: Bile Acids and Salts, Diarrhea. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Aase og Ejnar Danielsens Fond, Axel Muusfeldts Fond, Civilingeniør H.C. Bechgaard og hustru Ella Mary Bechgaards Fond.
Abstract (Originalsprache)
Background
Bile acid diarrhoea is often missed because gold standard nuclear medicine tauroselcholic [75‐Se] acid (SeHCAT) testing has limited availability. Empirical treatment effect has unknown diagnostic performance, whereas plasma 7α‐hydroxy‐4‐cholesten‐3‐one (C4) is inexpensive but lacks sensitivity.
Aims
To determine diagnostic characteristics of empirical treatment and explore improvements in diagnostics with potential better availability than SeHCAT.
Methods
This diagnostic accuracy study was part of a randomised, placebo‐controlled trial of colesevelam. Consecutive patients with chronic diarrhoea attending SeHCAT had blood and stool sampled. Key thresholds were C4 > 46 ng/mL and SeHCAT retention ≤10%. A questionnaire recorded patient‐reported empirical treatment effect. We analysed receiver operating characteristics and explored machine learning applied logistic regression and decision tree modelling with internal validation.
Results
Ninety‐six (38%) of 251 patients had SeHCAT retention ≤10%. The effect of empirical treatment assessed with test results for bile acid studies blinded had 63% (95% confidence interval 44%–79%) sensitivity and 65% (47%–80%) specificity; C4 > 46 ng/mL had 47% (37%–57%) and 92% (87%–96%), respectively. A decision tree combining C4 ≥ 31 ng/mL with ≥1.1 daily watery stools (Bristol type 6 and 7) had 70% (51%–85%) sensitivity and 95% (83%–99%) specificity. The logistic regression model, including C4, the sum of measured stool bile acids and daily watery stools, had 77% (58%–90%) sensitivity and 93% (80%–98%) specificity.
Conclusions
Diagnosis of bile acid diarrhoea using empirical treatment was inadequate. Exploration suggested considerable improvements in the sensitivity of C4‐based testing, offering potential widely available diagnostics. Further validation is warranted. ClinicalTrials.gov : NCT03876717.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Zealand University Hospital, Køge, Køge, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Gastroenterology and Hepatology, Aarhus University Hospital, Aarhus, Denmark.
- Unit of Medical and Surgical Gastroenterology, Hvidovre University Hospital, Hvidovre, Denmark.
- Department of Clinical Physiology and Nuclear Medicine, Hvidovre University Hospital, Hvidovre, Denmark.
ORCID-Profile: Christian Borup, Søren Peter German Jørgensen, Lars Kristian Munck
Förderung
- Aase og Ejnar Danielsens Fond
- Axel Muusfeldts Fond
- Civilingeniør H.C. Bechgaard og hustru Ella Mary Bechgaards Fond
- Fabrikant Vilhelm Pedersen og hustrus mindelegat by recommendation from the Novo Nordisk Foundation
- A.P. Møller og Hustru and Chastine Mc-Kinney Møller Fond til almene Formaal
- Overlaege Johan Boserup og Lise Boserups Legat
- Prosektor Axel Emil Søeborg Ohlsen og aegtefaelles Mindelegat
- Region Sjaelland
Zitieren
APA
Borup, C., Vinter-Jensen, L., Jørgensen, S. P. G., Wildt, S., Graff, J., Gregersen, T., Zaremba, A., Andersen, T. B., Nøjgaard, C., Timm, H. B., Lamazière, A., Rainteau, D., Hansen, S. H., Rumessen, J. J., & Munck, L. K. (2024). Prospective comparison of diagnostic tests for bile acid diarrhoea. Alimentary Pharmacology & Therapeutics, 59(1), 39-50. https://doi.org/10.1111/apt.17739
Vancouver
Borup C, Vinter-Jensen L, Jørgensen SPG, Wildt S, Graff J, Gregersen T, et al. Prospective comparison of diagnostic tests for bile acid diarrhoea. Alimentary Pharmacology & Therapeutics. 2024;59(1):39-50. doi:10.1111/apt.17739
BibTeX
@article{Borup2024,
author = {Borup, Christian and Vinter-Jensen, Lars and Jørgensen, Søren Peter German and Wildt, Signe and Graff, Jesper and Gregersen, Tine and Zaremba, Anna and Andersen, Trine Borup and Nøjgaard, Camilla and Timm, Hans Bording and Lamazière, Antonin and Rainteau, Dominique and Hansen, Svend Høime and Rumessen, Jüri Johannes and Munck, Lars Kristian},
title = {Prospective comparison of diagnostic tests for bile acid diarrhoea},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
volume = {59},
number = {1},
pages = {39--50},
doi = {10.1111/apt.17739}
}
EUVIMED